HMR-3562
UNII MJJ8RH7Z3D

Substance Identification & Data

This profile provides standardized clinical and technical data for Hmr-3562, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MJJ8RH7Z3D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 193752-41-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

MJJ8RH7Z3D

CAS Registry Number

193752-41-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

HMR-3562

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C43H64FN5O10

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

RSIQCUSPSFSWMQ-XXTFOGKVSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

6918484

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C[C@@]12[C@@H](CC)OC(=O)[C@](F)(C)C(=O)[C@H](C)[C@@H](O[C@]3([H])O[C@H](C)C[C@H](N(C)C)[C@H]3O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@]1([H])N(CCCCn4cnc(-c5cnccc5)c4)C(=O)O2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Hmr-3562. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(1R,2R,4R,6R,7R,8R,10S,13R,14S)-7-((2S,3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYL-TETRAHYDROPYRAN-2-YL)OXY-13-ETHYL-10-FLUORO-6-METHOXY-2,4,6,8,10,14-HEXAMETHYL-17-(4-(4-(3-PYRIDYL)IMIDAZOL-1-YL)BUTYL)-12,15-DIOXA-17-AZABICYCLO(12.3.0)HEPTADECANE-3,9,11,16-TETRONE

SYS

(3AS,4R,7S,9R,10R,11R,13R,15R,15AR)-4-ETHYL-7-FLUOROOCTAHYDRO-11-METHOXY-3A,7,9,11,13,15-HEXAMETHYL-1-(4-(4-(3-PYRIDINYL)-1H-IMIDAZOL-1-YL)BUTYL)-10-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)-2H-OXACYCLOTETRADECINO(4,3-D)OXAZOLE-2,6,8,14(1H,7H,9H)-TETRONE

SYS

2H-OXACYCLOTETRADECINO(4,3-D)OXAZOLE-2,6,8,14(1H,7H,9H)-TETRONE, 4-ETHYL-7-FLUOROOCTAHYDRO-11-METHOXY-3A,7,9,11,13,15-HEXAMETHYL-1-(4-(4-(3-PYRIDINYL)-1H-IMIDAZOL-1-YL)BUTYL)-10-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)-, (3AS,4R,7S,9R,10R,11R,13R,15R,15AR)-

SYS